technetium has been researched along with edda in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 6 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Imoto, T | 1 |
| Decristoforo, C; Mather, SJ | 1 |
| Cholewinski, W; Decristoforo, C; Donnemiller, E; Mather, SJ; Moncayo, R; Riccabona, G | 1 |
| He, J; Hnatowich, DJ; Rusckowski, M; Su, ZF | 1 |
| Decristoforo, C; Dietrich, H; Gabriel, M; Skvortsova, I; Virgolini, IJ; von Guggenberg, E | 1 |
| Bai, Y; Chang, Y; Chen, S; Li, Z; Teng, B | 1 |
| Biagini, SC; Blower, PJ; Dose, A; Meszaros, LK | 1 |
| Czepczyński, R; Gryczyńska, M; Ruchała, M; Szczepanek-Parulska, E; Wyszomirska, A | 1 |
| Amirmozafari, N; Erfani, M; Mazaheri Tehrani, M | 1 |
| Barisella, M; Fuoco, V; Lorenzoni, A; Maccauro, M; Verzoni, E | 1 |
| Fang, S; Feng, J; Jiang, Y; Ruan, Q; Zhang, J | 1 |
| Cardoza-Ochoa, DR; González-Díaz, JI; Sánchez-Vera, Y; Zárate-García, CD | 1 |
| Geramifar, P; Mazidi, SM; Mosayebnia, M; Nami, R; Rezaeianpour, M | 1 |
| Brown, CM; Gemmell, AJ; Ray, S; Small, A | 1 |
14 other study(ies) available for technetium and edda
| Article | Year |
|---|---|
[99mTc-ethylenediamine-N, N-diacetic acid; a radiopharmaceutical with tumor affinity].
Topics: Animals; Blood Chemical Analysis; Carcinoma, Ehrlich Tumor; Drug Evaluation; Edetic Acid; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Organotechnetium Compounds; Rabbits; Radionuclide Imaging; Technetium | 1984 |
Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.
Topics: Animals; Chelating Agents; Edetic Acid; Isotope Labeling; Male; Neoplasms, Experimental; Octreotide; Radionuclide Imaging; Rats; Rats, Wistar; Somatostatin; Technetium; Tissue Distribution | 1999 |
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.
Topics: Adult; Aged; Edetic Acid; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasms; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Technetium | 2000 |
In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.
Topics: Blood Proteins; Cells, Cultured; Edetic Acid; Endothelium, Vascular; Glycine; Humans; Hydrazines; Integrins; Ligands; Metabolic Clearance Rate; Nicotinic Acids; Oligopeptides; Protein Binding; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Umbilical Veins | 2003 |
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
Topics: Animals; Carcinoma, Medullary; Cysteine; Edetic Acid; Gastrins; Gene Expression Regulation, Neoplastic; Glycine; Humans; Kidney; Liver; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Rats; Receptor, Cholecystokinin B; Technetium; Thyroid Neoplasms; Tissue Distribution | 2007 |
Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging.
Topics: Chelating Agents; Edetic Acid; Glycine; Isotope Labeling; Ligands; Magnetic Resonance Imaging; Models, Chemical; Neoplasms; Radiopharmaceuticals; Technetium; Thymidine | 2007 |
Synthesis and evaluation of analogues of HYNIC as bifunctional chelators for technetium.
Topics: Chelating Agents; Chromatography, High Pressure Liquid; Coordination Complexes; Edetic Acid; Hydrazines; Isomerism; Mass Spectrometry; Nicotinic Acids; Technetium | 2011 |
Cerebellar metastasis of papillary thyroid carcinoma detected with somatostatin receptor scintigraphy.
Topics: Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Cerebellar Neoplasms; Edetic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; Octreotide; Radionuclide Imaging; Receptors, Somatostatin; Technetium; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
[
Topics: Animals; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Stability; Edetic Acid; Escherichia coli; Escherichia coli Infections; Hydrazines; Kidney; Mice; Nicotinic Acids; Radiopharmaceuticals; Technetium; Tissue Distribution | 2021 |
Unexpected Detection of Skeletal Muscle Renal Cell Carcinoma Metastasis With 99m Tc-EDDA/HYNIC-Tyr3-Octreotide (Tektrotyd) Scan.
Topics: Aged; Carcinoma; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Muscle, Skeletal; Octreotide; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Receptors, Somatostatin; Technetium | 2022 |
Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging.
Topics: Animals; Bacterial Infections; Mice; Norfloxacin; Organotechnetium Compounds; Radiopharmaceuticals; Technetium; Tissue Distribution | 2023 |
Incidental Diagnosis of Metastatic Breast Cancer in a Man With 99m Tc-PSMA SPECT/CT.
Topics: Breast Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Single Photon Emission Computed Tomography Computed Tomography; Technetium; Tomography, X-Ray Computed | 2023 |
Vimentin-targeted radiopeptide 99m Tc-HYNIC-(tricine/EDDA)-VNTANST: a promising drug for pulmonary fibrosis imaging.
Topics: Animals; Cell Line, Tumor; Humans; Intermediate Filaments; Mice; Organotechnetium Compounds; Pulmonary Fibrosis; Radiopharmaceuticals; Technetium; Tissue Distribution; Vimentin | 2023 |
Quantitative uptake in 99m Tc-EDDA/HYNIC-TOC somatostatin receptor imaging - the effect of long-acting release somatostatin analogue therapy.
Topics: Humans; Neoplasms; Octreotide; Organotechnetium Compounds; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Technetium | 2023 |